Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Join | Sign in
Home>Resources>Webcasts>This Webcast
  Webcasts
Dynamic Multi-Analyte Testing Technology for Accelerated Biomarker Measurement
Patrick van den Bogaard, Biocartis, speaking at Microarray World Congress 2012
Date Posted: Monday, May 06, 2013
Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Related Content

Biocartis and Fast-track Diagnostics Sign Strategic Collaboration
Both Companies aim to develop a range of multiplex tests on the Biocartis Idylla™ system each detecting a range of infectious disease pathogens.
Wednesday, May 27, 2015
Biocartis And Microbiome Collaborate
Collaboration aims to develop rapid and sensitive sepsis test.
Thursday, April 09, 2015
Biocartis Spins Out Life Sciences Multiplex Platform Evalution into Mycartis
Company has combined its Swiss Evalution business unit with Pronota NV to form MyCartis.
Saturday, September 06, 2014
Biocartis Raises EUR 64.5 Million
Investment supports commercial roll-out of Idylla™, Biocartis’ flagship molecular diagnostics system, and the development of the system’s menu of diagnostics tests.
Friday, September 05, 2014
Invetech and Biocartis Announce Biomarker Collaboration
Agreement supporting global development and manufacture of instrument to analyze protein and nucleic acid biomarkers continues multi-year relationship.
Wednesday, April 16, 2014
Biocartis and VIB Join Forces
Company will develop a new CRC assay for MSI biomarker detection.
Monday, December 09, 2013
Biocartis Announces the End of its Alliance with bioMérieux
Agreement for the development and commercialization of the integrated molecular biology system, Idylla™.
Friday, November 29, 2013
Biocartis Announces Completion of EUR 30 Million Series E Equity Fundraising
Company poised for 2014 commercial launch.
Thursday, November 07, 2013
Biocartis and Hospital del Mar Join Forces
License agreement to develop diagnostic colon cancer test.
Monday, October 21, 2013
Scientific News
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Scientists are Designing Decoy Drugs to Fool Cancer
Study shows potential of drugs that can target the Notch switch with reduced toxicity.
Viral Immunotherapy For Skin Cancer Shows Patient Benefit
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown.
Seeing the Action
Researchers have developed a way to observe both the forces present and the behavior that occurs during cell hemifusion; the merging of the lipid bi-layers of two cells.
Non-Aqueous Solvent Supports DNA Nanotech
Researchers at the Georgia Institute of Technology have now shown that they can assemble DNA nano-structures in a solvent containing no water.
‘Rosetta Stone’ for Prostate Cancer Mutations
Scientists have produced a comprehensive genetic map of the mutations in prostate cancer that have spread across the body.
From Worker to Queen at the Drop of a Gene
Biologists have found that the hierarchical fate of one of nature's most important pollinators comes down to which genes are "turned on or off".
First Step Towards Global Attack on Potato Blight
European researchers and companies concerned with the potato disease phytophthora will work more closely with parties in other parts of the world.
Bioresorbable Electronic Stent Could Provide Feedback, Therapy
Researchers have developed and tested a drug releasing electronic stent which could significantly reduce the risk associated with traditional mesh tube stents.
Tiny Heart, Big Promise
Researchers have discovered a new source of cells that can develop into coronary vessels.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters